ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Startups range from in-home therapy to software for reducing readmissions

March 30, 2012 2:48 pm by | 0 Comments

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Related Topics: ,
Previous Story

Regulatory attorney: Appealing FDA rejections is bulk of practice

Next Story

2012 HIT advice: Convert vendors to HIPAA helpers, master data integration

Stephanie Baum

By Stephanie Baum

Stephanie Baum is the East Coast Innovation Reporter for MedCityNews.com. She enjoys covering healthcare startups across health IT, drug development and medical devices and innovations deployed to improve medical care. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's written for The Christian Science Monitor, Dow Jones & Co. and United Business Media.
Visit website | More posts by Author
0 comments
  Livefyre
Newest | Oldest

Stay Up To Date

Be the first to hear the latest industry news with our newsletters or by following us on Twitter & Facebook.

Video

Mobile health urinalysis diagnostic draws FDA scrutiny

Mobile health urinalysis diagnostic draws FDA scrutiny

Telehealth startup 2nd.MD CEO says he got encouragement from Eric Topol

Telehealth startup 2nd.MD CEO says he got encouragement from Eric Topol

GE offers an inside look at how it’s innovating in cancer care (video)

GE offers an inside look at how it’s innovating in cancer care (video)

5 Hot Startups

32 life science and health IT startups will compete in MassChallenge 2013

32 life science and health IT startups will compete in MassChallenge 2013

Startups take note: Healthcare reform = opportunity

Startups take note: Healthcare reform = opportunity

Nurses want “healthcare versions” of user-friendly personal apps

Nurses want “healthcare versions” of user-friendly personal apps

Remote Medical scores $8M grant, predicts 60 percent revenue growth

Remote Medical scores $8M grant, predicts 60 percent revenue growth

After a restructure and an axed Merck deal, Acumen gains $20M for novel Alzheimer’s drug

After a restructure and an axed Merck deal, Acumen gains $20M for novel Alzheimer’s drug

Recent Comments

Research Center

Jobs Board

Next Story
2012 HIT advice: Convert vendors to HIPAA helpers, master data integration
Close